Multispan, Inc.

Executive Summary

Multispan, Inc. is a privately held contract research organization (CRO) specializing in G-protein-coupled receptor (GPCR) drug discovery and cell engineering. Founded in 1998 and headquartered in Hayward, California, the company has established a reputation for providing integrated solutions, including custom cell line generation, assay development, and high-throughput screening services. Its core expertise lies in GPCR targets, which are critical for therapeutic areas such as neurology, endocrinology, and oncology. By offering end-to-end support from target validation to lead optimization, Multispan enables pharmaceutical and biotechnology clients to accelerate their drug discovery programs. Despite operating in a competitive CRO landscape, the company's decades-long focus on GPCRs positions it as a specialized partner for complex membrane protein targets. However, the absence of recent funding rounds, revenue disclosures, or pipeline visibility limits near-term growth projections. The company remains bootstrapped and privately held, with no public information on partnerships or equity raises, suggesting a conservative growth trajectory. Its long-standing presence and niche expertise provide a stable foundation, but scalability may be constrained without external investment.